Trial intelligence / Profile preview

Fosamax Plus 70/5600 in Osteoporosis

NCT01437111Phase 3Completed

Sponsor
Organon & Co.
Start
Oct 2011
Primary completion
Dec 2012
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
01

Overview

A Phase 3 trial of alendronate + cholecalciferol in osteoporosis, sponsored by Organon & Co.. Started Oct 2011; status: completed.

02

Drugs

alendronate + cholecalciferol
03

Conditions

osteoporosis

Beyond the preview

Go deeper on NCT01437111.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01437111.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call